The Numolux Group


November 2022 The inactivated CoronaVac vaccine, manufactured by Sinovac Biotech arrived in South Africa, at ORTambo airport on Tuesday 8 November 2022.

At the Numolux Health Symposium held on 28 October in Pretora, South Africa – Department ofInternational Relations and Co-operation (DIRCO) Mr. Ben

Dr. Sarita Naidoo, Head of Clinical Research at the Numolux Group has been focusing on the clinicaltrial trends in Africa, the existing

In the build up to the 2023 BRICS Summit to be held in South Africa, the Numolux Group hosted a symposium in

Ongoing Study blogA Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of COVID-19 Vaccine (Vero

Launch of the Canal Walk Medical, Wellness and Clinical Trial Centre eventsThe Numolux Group, in partnership with Dr MS Ismail celebrated the